Fortrea to Attend Jefferies Global Healthcare Conference
Fortrea (Nasdaq: FTRE) will participate in the Jefferies Global Healthcare Conference/b) in New York.
Rhea-AI Summary
Fortrea (Nasdaq: FTRE) will participate in the Jefferies Global Healthcare Conference/b) in New York.CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations Tracy Krumme will join a fireside chat on Thursday, June 4, 2026 at 8:45 AM EDT, with a live webcast and replay available.
Details
News Market Reaction – FTRE
On Jun 3, the first trading day after this news, FTRE closed 1.76% above the previous close.
Data tracked by StockTitan Argus for the Jun 3 session.
Key Figures
- Conference date
- June 4, 2026
- Jefferies Global Healthcare Conference appearance
- Presentation time
- 8:45 AM EDT
- Jefferies conference fireside chat
Historical Context
-
Q1 2026 results with adjusted profitability and reaffirmed 2026 guidance.
-
Announcement of Q1 2026 release date and conference call logistics.
-
Launch of Fortrea Intelligent Technology suite for smarter trial execution.
-
Grants of 130,000 RSUs to new employees under inducement plan.
-
Q4 and 2025 results with guidance and backlog/book-to-bill disclosure.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
cro medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
DURHAM, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq: FTRE), a leading global contract research organization (“CRO”), today announced that that CEO Anshul Thakral, CFO Jill McConnell, and SVP of Investor Relations, Tracy Krumme will participate in the following conference:
Jefferies Global Healthcare Conference (NYC)
Date: Thursday, June 4, 2026
Time: 8:45 AM EDT
Format: Fireside Chat
To register for the live webcast, please click here. A replay will be available in the Events & Presentations section of Fortrea’s Investor Relations website. Investors interested in one-on-one or group meetings should contact their Jefferies representatives.
About Fortrea
Fortrea (Nasdaq: FTRE) is a leading global provider of clinical development solutions to the life sciences industry. We partner with emerging and large biopharmaceutical, biotechnology, medical device and diagnostic companies to drive healthcare innovation that accelerates life changing therapies to patients. Fortrea provides phase I-IV clinical trial management, clinical pharmacology and consulting services. Fortrea’s solutions leverage three decades of experience spanning more than 20 therapeutic areas, a passion for scientific rigor, exceptional insights and a strong investigator site network. Our talented and diverse team, operating across approximately 100 countries, is scaled to deliver focused, agile solutions to clients globally. Learn more about how Fortrea is streamlining drug development at Fortrea.com and follow us on LinkedIn, X and Bluesky.
Fortrea Contacts
Tracy Krumme (Investors) – 984-385-6707, tracy.krumme@fortrea.com
Sue Zaranek (Media) – 919-943-5422, media@fortrea.com
Kate Dillon (Media) – 646-818-9115, kdillon@prosek.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.